[An anti-phlogistic effect of BCP (5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine) on experimentally induced ocular inflammation].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D005128:Eye Diseases / Q000139:chemically induced / Q000188:drug therapy*; D007249:Inflammation / Q000188:drug therapy; D007273:Injections, Intramuscular; D011743:Pyrimidines / Q000627:therapeutic use*; D011817:Rabbits
D000893:Anti-Inflammatory Agents; D011743:Pyrimidines; D003907:Dexamethasone